Andrew J. Fromkin, Director at Immunovant, Inc. (IMVT), sold 44,498 shares at $23.14 ($1.0M) on 2025-12-01, disclosed to the SEC on 2025-12-03.
Scheduled sale ($1.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.14 | 19,351 | $448K | 43.3% |
| 2 | $23.14 | 19,351 | $448K | 43.3% |
| 3 | $23.95 | 2,898 | $69K | 6.7% |
| 4 | $23.95 | 2,898 | $69K | 6.7% |
| Total | $23.25 avg | 44,498 | $1.0M | 100% |
| Filing → |
| IMVT | SELL | 2023-12-05 | $981K | — | Filing → |
| IMVT | BUY | 2021-08-11 | $43K | — | Filing → |